Furthermore, this combination has less weight gain and hypoglycemia than insulin treatment alone because of the weight-losing effects of GLP-1 RAs and usually less insulin dosage needed to achieve better glycemic control compared with insulin treatment alone. The gene discussed is GLP1R; the disease is Hypoglycemia.